bisoprolol has been researched along with Psoriasis in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waqar, S | 1 |
| Sarkar, PK | 1 |
1 other study available for bisoprolol and Psoriasis
| Article | Year |
|---|---|
Exacerbation of psoriasis with beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Bisoprolol; Calcium; Coronary Artery Bypass; Coronary Disease; Follow-U | 2009 |